Laurus Labs debuted at Rs 490.00 on the BSE, up by 62 points or 14.49% from its issue price of Rs 428.
The scrip is currently trading at Rs 476.25, up by 48.25 points or 11.27% from its issue price. It has touched a high and low of Rs 498.00 and Rs 475.00 respectively. So far 19,17,000 shares were traded on the counter.
The offering, which was open for subscription between December 6 and December 8, was subscribed 4.52 times. The issue price was fixed at Rs 428 per share i.e. at upper end of price band of Rs 426-428 apiece.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas.
